A new report finds that a majority of Americans think the U.S. should be a world leader in science, but Democrats ...

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra ...

Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an ...

Artificial intelligence promises to accelerate scientific discovery and open new frontiers of inquiry. But new research from ...

Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the ...

Scientific uncertainty persists around 3I/ATLAS after anomalous observations and a CIA FOIA response, despite NASA’s public ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular ...

The consequences could be severe. With paylines at most NIH Institutes well below 10 percent, every award not based on merit ...

From drug design to climate modelling, artificial intelligence can process data at scales far beyond human capacity.